Splenic Marginal Zone Lymphoma (SMZL) is indeed a rare form, making up only about 1-2% of all non-Hodgkin lymphoma cases. It's considered a slow-growing (low-grade) lymphoma, and many people with SMZL have positive outcomes and can live for many years after diagnosis. Common symptoms include
- Pain in the abdomen or left Show Full Answer
Splenic Marginal Zone Lymphoma (SMZL) is indeed a rare form, making up only about 1-2% of all non-Hodgkin lymphoma cases. It's considered a slow-growing (low-grade) lymphoma, and many people with SMZL have positive outcomes and can live for many years after diagnosis. Common symptoms include:
- Pain in the abdomen or left shoulder
- Feeling full in the upper abdomen
- Getting full quickly when eating
- An enlarged spleen (splenomegaly)
It's worth noting that about 25% of people don't have symptoms early on, and some may not require immediate treatment. Treatment options have expanded to include newer therapies like BTK inhibitors, which are helping improve outcomes for those with refractory/relapsed SMZL. Your healthcare team can provide more specific information about your individual prognosis and treatment options.
June 30, 2025